Karthaus HF - Search Results

1

Characterization of human prostate cancer, benign prostatic hyperplasia and normal prostate by in vitro 1H and 31P magnetic resonance spectroscopy.

Cornel EB, Smits GA, Oosterhof GO, Karthaus HF, Deburyne FM, Schalken JA, Heerschap A. Cornel EB, et al. Among authors: karthaus hf. J Urol. 1993 Dec;150(6):2019-24. doi: 10.1016/s0022-5347(17)35957-8. J Urol. 1993. PMID: 7693985

2

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

Hessels D, Klein Gunnewiek JM, van Oort I, Karthaus HF, van Leenders GJ, van Balken B, Kiemeney LA, Witjes JA, Schalken JA. Hessels D, et al. Among authors: karthaus hf. Eur Urol. 2003 Jul;44(1):8-15; discussion 15-6. doi: 10.1016/s0302-2838(03)00201-x. Eur Urol. 2003. PMID: 12814669

3

Biomarkers for the diagnosis of prostatic inflammation in benign prostatic hyperplasia.

Robert G, Smit F, Hessels D, Jannink S, Karthaus HF, Aalders T, Jansen K, de la Taille A, Mulders PF, Schalken JA. Robert G, et al. Among authors: karthaus hf. Prostate. 2011 Nov;71(15):1701-9. doi: 10.1002/pros.21387. Epub 2011 Mar 28. Prostate. 2011. PMID: 21446005

4

Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.

Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HF, Schaafsma HE, Debruyne FM, Isaacs WB. Umbas R, et al. Among authors: karthaus hf. Cancer Res. 1992 Sep 15;52(18):5104-9. Cancer Res. 1992. PMID: 1516067

5

Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer.

Umbas R, Isaacs WB, Bringuier PP, Schaafsma HE, Karthaus HF, Oosterhof GO, Debruyne FM, Schalken JA. Umbas R, et al. Among authors: karthaus hf. Cancer Res. 1994 Jul 15;54(14):3929-33. Cancer Res. 1994. PMID: 7518346

6

Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization.

Tamimi Y, van der Poel HG, Denyn MM, Umbas R, Karthaus HF, Debruyne FM, Schalken JA. Tamimi Y, et al. Among authors: karthaus hf. Cancer Res. 1993 Nov 15;53(22):5512-6. Cancer Res. 1993. PMID: 8221692

7

DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.

Bussemakers MJ, van Bokhoven A, Verhaegh GW, Smit FP, Karthaus HF, Schalken JA, Debruyne FM, Ru N, Isaacs WB. Bussemakers MJ, et al. Among authors: karthaus hf. Cancer Res. 1999 Dec 1;59(23):5975-9. Cancer Res. 1999. PMID: 10606244

8

The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance.

van Gils MP, Hessels D, van Hooij O, Jannink SA, Peelen WP, Hanssen SL, Witjes JA, Cornel EB, Karthaus HF, Smits GA, Dijkman GA, Mulders PF, Schalken JA. van Gils MP, et al. Among authors: karthaus hf. Clin Cancer Res. 2007 Feb 1;13(3):939-43. doi: 10.1158/1078-0432.CCR-06-2679. Clin Cancer Res. 2007. PMID: 17289888

9

A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization.

Tamimi Y, van der Poel HG, Karthaus HF, Debruyne FM, Schalken JA. Tamimi Y, et al. Among authors: karthaus hf. Br J Cancer. 1996 Aug;74(4):573-8. doi: 10.1038/bjc.1996.403. Br J Cancer. 1996. PMID: 8761372 Free PMC article.

10

Manual derotation of the twisted spermatic cord.

Cornel EB, Karthaus HF. Cornel EB, et al. Among authors: karthaus hf. BJU Int. 1999 Apr;83(6):672-4. doi: 10.1046/j.1464-410x.1999.00003.x. BJU Int. 1999. PMID: 10233577

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters